Navigation Links
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
Date:6/11/2008

- RECIST-defined objective response supports expansion of Simon 2-Stage

designed trial -

BRANFORD, Conn., June 11 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today that its Phase II Trial evaluating CR011-vcMMAE for the treatment of patients with unresectable Stage III or Stage IV melanoma has met the efficacy criteria for advancement to the second stage of enrollment. Of the first six evaluable patients in this Phase II trial one patient has had a confirmed objective response, as measured by RECIST criteria. As part of the Simon 2-Stage design the trial will now expand to enroll a total of 32 patients.

"We are very encouraged by the emerging clinical efficacy of CR011-vcMMAE. We believe that this objective response confirms the initial activity observed in the Phase I trial, the results of which were reported earlier this month at ASCO," commented Dr. Timothy Shannon, President and Chief Executive Officer of CuraGen Corporation. "This trial is enrolling well, and we expect the data to quickly mature allowing us to provide further updates from the study later in the second half of this year."

Dr. Ronit Simantov, Vice President and Chief Medical Officer commented, "There remains a substantial unmet need for patients with advanced melanoma. As we continue to evaluate CR011-vcMMAE 1.88 mg/kg given once every three weeks in this ongoing Phase II trial, we are also looking to further optimize the activity of CR011-vcMMAE by actively exploring alternative dosing schedules including more frequent intravenous administration of this novel agent."

This ongoing open-label, multi-center Phase II study e
'/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Acsis Inc., the market leader for supply ... that John DiPalo , Acsis, Chief Strategy Officer, ... Chain Executive 2015 Provider Pro to Know. The ... to help prepare their companies, and customers, supply chains ... year,s list of Provider Pros to Know is featured ...
(Date:2/27/2015)... WASHINGTON , Feb. 27, 2015  Following ... Means Committee that moved H.R. 284, the Medicare ... the American Association for Homecare (AAHomecare) released a ... quick action to pass the legislation. ... in the House Ways and Means Committee is ...
(Date:2/27/2015)... 2015 - ... di monitoraggio dell,infarto congestizio (CHF - Congestive Heart ...     Vectorious Medical Technologies, ... per il monitoraggio cardiaco destinato a pazienti affetti ... aver concluso una raccolta di finanziamenti per 5 ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... II Trial Results,For Novel Oral Thrombin Receptor ... American College Of Cardiology/i2 Summit, KENILWORTH, N.J., ... today that results of the,Phase II trial ... (TRA),SCH 530348 will be presented at the ...
... SAN CARLOS, Calif., March 19, 2007 /PRNewswire-FirstCall/ --,Nuvelo, ... ANTHEM,(Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 ... c2,(rNAPc2) in patients with non-ST-elevation acute coronary syndromes,(NSTE-ACS) ... the of,Cardiology (ACC) 56th Annual Scientific Session taking ...
Cached Medicine Technology:Media Advisory: ACC Updated Schedule 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 3
(Date:2/27/2015)... Miami Beach, Florida (PRWEB) February 27, 2015 ... largest non-profit organization devoted exclusively to funding innovative lymphoma ... series of education programs, outreach initiatives and patient services ... the South Florida community, returning to the greater Miami ... the La Gorce Country Club in Miami Beach on ...
(Date:2/27/2015)... 2015 "After studying the benefits and risks ... prenatal spina bifida repair may outweigh the risks for those ... range," says Fetal Care Institute Director Dr. Mike Vlastos, ... specialist. "The goal of the study is to gain ... and their unborn babies." , Studies have shown that mothers ...
(Date:2/27/2015)... February 27, 2015 Over 440,000 patients die ... the equivalent of two jumbo jet airplanes crashing each day. ... band together in an effort to do all they can ... Dr. Richard Carmona, the 17th U.S. Surgeon General, discusses the ... to be able to address safety issues to ensure that ...
(Date:2/27/2015)... Jupiter Medical Center and The Mount Sinai ... New York at Jupiter Medical Center, to enhance cardiac ... , “This innovative collaboration with Mount Sinai Heart New ... care in our very own backyard,” said John D. ... Center. “This kind of innovative thinking will transform cardiac ...
(Date:2/27/2015)... 2015 Muscular Dystrophy Association research ... at Duke University, recently announced a potentially game-changing ... men with Duchenne muscular dystrophy (DMD). The results ... Gersbach will discuss their implications at MDA's 2015 ... Washington, D.C. , Background: Gersbach and team ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 2Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 3Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2
... Younger at American Society of ... Plastic Surgeons Annual Meeting, BALTIMORE, Oct. 28 ... to looking younger. In fact,plastic surgeons analyze facial features and configurations ... in, say,presenters today at the American Society of Plastic Surgeons (ASPS) ...
... diagnosis is vital; symptoms can often mimic digestive problems , , ... had a reputation as a silent killer, because many people ... But women suffering from the disease knew differently. They knew ... patient. , "Survivors for years have said there are symptoms ...
... a condition called gastroschisis varies greatly by hospital, according to ... have a hole in their abdomen near the umbilical cord. ... the only abdominal anomaly, is fairly easy to repair, and ... suggest that in some hospitals, far fewer babies who should ...
... men born with a severe urological anomaly in which ... more robust sexual lives than women born with the ... urologists at the Johns Hopkins Childrens Center. The condition, ... surgeries throughout infancy and childhood and into early adolescence.The ...
... Four More Years of Borrowing for Iraq War,and Denying ... Howard Dean,Chairman of the Democratic National Committee, delivered the ... while all of the,Republican presidential candidates support borrowing $196 ... $7 billion next year for the,bipartisan plan to provide ...
... ... Meeting, BALTIMORE, Oct. 27 ... are making headlines. But are these procedures really ready to,be a part ... new discoveries or just "buyer beware" marketing,hype this week at the American ...
Cached Medicine News:Health News:Facelift, Botox, or Both? Depends Upon Your Decade of Life 2Health News:Facelift, Botox, or Both? Depends Upon Your Decade of Life 3Health News:New Guidelines Should Improve Ovarian Cancer Detection 2Health News:New Guidelines Should Improve Ovarian Cancer Detection 3Health News:Democratic Radio Address 2Health News:Democratic Radio Address 3Health News:Non-Invasive Fat-Melting Procedures - Hype or Reality? 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: